Coherent Capital

Biohacking Investment Pitch (and Panel)

Only June 25th, we’ll be hosting a Biohacking and HealthTech Investments Pitch.

Biohacking Congress and Coherent Capital invite you to join our Virtual Meetup, a networking event for entrepreneurs, investors, and experts from BioTech and HealthTech Industries. Date and time: June 25, 11 am - 2pm PT; 2 pm - 5 pm ET, 6 pm - 9 pm GMT, 7 pm - 10 pm UK.

biohacking healthtech funds.jpg

The Meetup will start with the Panel Discussion: "Innovations in LongevityTech, HealthTech and BioTech Industries. Opportunities for Investment". Venture Capital Investors and Entrepreneurs will discuss the topic on a virtual panel.

The second half of the meetup with feature HealthTech Startup pitches. Each entrepreneur will have 10 minutes for their Pitch which will be followed by a Q&A session with invited VCs.

biohacking healthtech startups.jpg

Guest Speakers:

Adam Dakin, Managing Director, Dreamit Ventures
Kate Batz, Managing Partner, Longevity Capital
Meghan Cross, Partner, Amplifyher Ventures
Max Zamkow, Partner, Third Act Ventures
Guenther Brueggenwerth, LifeHub UK Lead Radiology, AI and Open Innovation

Venture Funds:

Agroecology Capital
Longevity Capital
Dreamit Ventures
Sartorian Ventures
Third Act Ventures
Amplifyher Ventures
Astir Ventures
SOSV
Rising Tide
Tau Ventures
M. VENTURES
Bayer LifeHub UK

At Coherent Capital, we focus on facilitating strategic investor relationships for promising, disruptive startup companies with a focus on healthtech and biohacking investments.

Maggie SaundersJune 22, 2020

Securities are offered through Finalis Securities LLC Member FINRA/SIPC. Coherent Capital, LLC and Finalis Securities LLC are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck

CoherentCapital.com is a website operated by Coherent Capital, LLC, a privately held California limited liability company. Coherent Capital, LLC provides financial and strategic advisory, consulting services, mergers and acquisitions services, fairness opinions, etc.].

Coherent Capital, LLC is not a registered broker-dealer, and Finalis Securities LLC and Coherent Capital, LLC are separate, unaffiliated entities.

Finalis does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security. You can review the brokercheck for Finalis here. This website is intended solely for qualified investors. Investments in private offerings and startup investments in particular are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in such offerings. Companies seeking startup investments tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors may receive restricted stock that may be subject to holding period requirements. Investments in early-stage private companies should only be part of your overall investment portfolio. Furthermore, the allocation to this asset sub-class may be best fulfilled through a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest. Business Continuity Plan for Finalis.